| |
 |
|
Class Information
Number: 435/235.1
Name: Chemistry: molecular biology and microbiology > Virus or bacteriophage, except for viral vector or bacteriophage vector; composition thereof; preparation or purification thereof; production of viral subunits; media for propagating
Description: Subject matter excluding viral and bacteria-phage vectors, but including a virus or bacteriophage which is a microorganism that (a) consists of a protein shell around a nucleic acid core of either ribonucleic acid or deoxyribonucleic acid, and (b) is capable of independently entering a host microorganism, and (c) requires a host microorganism, having both ribonucleic acid and deoxyribonucleic acid, to replicate, compositions thereof under the class definition not elsewhere provided for, processes of preparation or propagation, media for propagating, processes of purifying the microorganism and processes of producing viral subunits.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7619060 |
Cytoplasmic polyhedrosis virus protein complex of a polyhedrin and a VP3 polypeptide |
Nov. 17, 2009 |
| 7618802 |
Compositions of coronaviruses with a recombination-resistant genome |
Nov. 17, 2009 |
| 7611884 |
Toxoplasma gondii nucleic acid molecules |
Nov. 3, 2009 |
| 7608449 |
Methods and compositions related to high-titer pseudotyped retroviruses |
Oct. 27, 2009 |
| 7604977 |
Methods and compositions for inhibiting HIV infection |
Oct. 20, 2009 |
| 7604935 |
Soluble rubella E1 envelope protein variants |
Oct. 20, 2009 |
| 7601825 |
Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer |
Oct. 13, 2009 |
| 7601490 |
Development of influenza A antivirals |
Oct. 13, 2009 |
| 7598071 |
Infectious clone of human parvovirus B19 and methods |
Oct. 6, 2009 |
| 7598070 |
Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith |
Oct. 6, 2009 |
| 7592433 |
Polynucleotides encoding cyclotide-like structures |
Sep. 22, 2009 |
| 7592170 |
Selective precipitation of viruses using polyectrolytes |
Sep. 22, 2009 |
| 7592169 |
Methods and compositions for treatment and prevention of HSV-2 infections and conditions |
Sep. 22, 2009 |
| 7588769 |
Viruses encoding mutant membrane protein |
Sep. 15, 2009 |
| 7585667 |
Negative strand RNA virus replicon |
Sep. 8, 2009 |
| 7585657 |
Signal for packaging of influenza virus vector |
Sep. 8, 2009 |
| 7585641 |
Immunoassay and method of use |
Sep. 8, 2009 |
| 7582614 |
Use of myxoma virus for the therapeutic treatment of cancer and chronic viral infection |
Sep. 1, 2009 |
| 7582447 |
DNA encoding a testicular carnitine transporter |
Sep. 1, 2009 |
| 7582303 |
Avian hepatitis E virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis E |
Sep. 1, 2009 |
| 7582291 |
Bacteriophage lysins for Enterococcus faecalis, Enterococcus faecium and other bacteria |
Sep. 1, 2009 |
| 7579142 |
Methods for purification of bacterial cells and components |
Aug. 25, 2009 |
| 7579007 |
Production of "biological carriers" for induction of immune responses and inhibition of viral replication |
Aug. 25, 2009 |
| 7575911 |
Hepatocyte bioreactor system for long term culture of functional hepatocyte spheroids |
Aug. 18, 2009 |
| 7572621 |
Detection, characterization and treatment of viral infection and methods thereof |
Aug. 11, 2009 |
| 7572620 |
H3 equine influenza A virus |
Aug. 11, 2009 |
| 7572453 |
Chimeric alphavirus replicon particles |
Aug. 11, 2009 |
| 7569383 |
Chimeric flavivirus vectors |
Aug. 4, 2009 |
| 7569340 |
Nanoarrays of single virus particles, methods and instrumentation for the fabrication and use thereof |
Aug. 4, 2009 |
| 7566562 |
Culturing circular ssDNA viruses for the production of vaccines |
Jul. 28, 2009 |
| 7563881 |
Nucleic acid encoding polypeptide involved in cellular entrance of the PRRS virus |
Jul. 21, 2009 |
| 7563617 |
Hybrid adenovirus/adeno-associated virus vectors and methods of use thereof |
Jul. 21, 2009 |
| 7563449 |
Methods for reducing cattle reproductive diseases |
Jul. 21, 2009 |
| 7557199 |
Hepatitis C virus vaccine |
Jul. 7, 2009 |
| 7556940 |
Assembly of wild-type and chimeric influenza virus-like particles (VLPs) |
Jul. 7, 2009 |
| 7556812 |
Dengue and West Nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications |
Jul. 7, 2009 |
| 7550284 |
Production of vaccines |
Jun. 23, 2009 |
| 7550283 |
Bacteriophage for lysis of Methylobacterium and compositions and uses thereof |
Jun. 23, 2009 |
| 7550148 |
Targeting of Herpes simplex virus to specific receptors |
Jun. 23, 2009 |
| 7547773 |
Nucleic acid molecules encoding prostate specific antigen oligo epitope peptides |
Jun. 16, 2009 |
| 7544791 |
Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS |
Jun. 9, 2009 |
| 7544788 |
Isolated nucleic acid molecule encoding a neurotrophic growth factor |
Jun. 9, 2009 |
| 7544362 |
N protein mutants of porcine reproductive and respiratory syndrome virus |
Jun. 9, 2009 |
| 7541038 |
Fusogenic, self-propagating blebs as immunogenic compositions |
Jun. 2, 2009 |
| 7538201 |
Recombinant herpesvirus and uses thereof |
May. 26, 2009 |
| 7537924 |
Virus strains |
May. 26, 2009 |
| 7537768 |
Influenza virus vaccine composition and methods of use |
May. 26, 2009 |
| 7534603 |
Fusion protein delivery system and uses thereof |
May. 19, 2009 |
| 7534596 |
Method and device for producing vaccine |
May. 19, 2009 |
| 7531342 |
Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences |
May. 12, 2009 |
|
|
|
